APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chronic Gastritis Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chronic Gastritis Treatment Industry Growth and Trends Forecast to 2032

Report ID 173977910119 December 2025102 pages

Choose your research edition.

Industry ResearchChronic Gastritis Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Gastritis Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Chronic Gastritis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Gastritis Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Gastritis Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global Chronic Gastritis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chronic Gastritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chronic Gastritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Gastritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Chronic Gastritis Treatment market include Alchem International, Cipla, Katsura Chemical, Lupin Ltd, Microbiotix, Perrigo Pharmaceutical, RESONANCE LABORATORIES, ROLABO OUTSOURCING and SAURAV CHEMICALS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chronic Gastritis Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chronic Gastritis Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chronic Gastritis Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chronic Gastritis Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Chronic Gastritis Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chronic Gastritis Treatment Market by Company

Alchem International

Cipla

Katsura Chemical

Lupin Ltd

Microbiotix

Perrigo Pharmaceutical

RESONANCE LABORATORIES

ROLABO OUTSOURCING

SAURAV CHEMICALS

AstraZeneca

Hangzhou Vega

Wuhan Senwayer Century

Chronic Gastritis Treatment Segment by Type

H2 Antagonists

Antacids

Proton Pump Inhibitors

Others

Chronic Gastritis Treatment Segment by Application

Drug Stimulate

Stress

Irritant

Virus Infection

Others

Chronic Gastritis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Gastritis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Gastritis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Gastritis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Chronic Gastritis Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Chronic Gastritis Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Chronic Gastritis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Chronic Gastritis Treatment Market Share by Region (2021-2026) Table 4. Global Chronic Gastritis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Chronic Gastritis Treatment Market Share by Region (2027-2032) Table 6. Global Chronic Gastritis Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Chronic Gastritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Chronic Gastritis Treatment Market Size Share by Type (2021-2026) Table 9. Global Chronic Gastritis Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Chronic Gastritis Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Chronic Gastritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Chronic Gastritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Chronic Gastritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Chronic Gastritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Chronic Gastritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Chronic Gastritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Chronic Gastritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Chronic Gastritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Chronic Gastritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Chronic Gastritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Chronic Gastritis Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Chronic Gastritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Chronic Gastritis Treatment Market Size Share by Application (2021-2026) Table 24. Global Chronic Gastritis Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Chronic Gastritis Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Chronic Gastritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Chronic Gastritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Chronic Gastritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Chronic Gastritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Chronic Gastritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Chronic Gastritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Chronic Gastritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Chronic Gastritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Chronic Gastritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Chronic Gastritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Chronic Gastritis Treatment Industry Trends Table 37. Chronic Gastritis Treatment Industry Drivers Table 38. Chronic Gastritis Treatment Industry Opportunities and Challenges Table 39. Chronic Gastritis Treatment Industry Restraints Table 40. Global Chronic Gastritis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Chronic Gastritis Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Chronic Gastritis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Chronic Gastritis Treatment Key Company Headquarters & Area Served Table 44. Global Chronic Gastritis Treatment Company, Product Type & Application Table 45. Global Chronic Gastritis Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Chronic Gastritis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Alchem International Company Information Table 49. Alchem International Business Overview Table 50. Alchem International Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Alchem International Chronic Gastritis Treatment Product Portfolio Table 52. Alchem International Recent Development Table 53. Cipla Company Information Table 54. Cipla Business Overview Table 55. Cipla Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Cipla Chronic Gastritis Treatment Product Portfolio Table 57. Cipla Recent Development Table 58. Katsura Chemical Company Information Table 59. Katsura Chemical Business Overview Table 60. Katsura Chemical Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Katsura Chemical Chronic Gastritis Treatment Product Portfolio Table 62. Katsura Chemical Recent Development Table 63. Lupin Ltd Company Information Table 64. Lupin Ltd Business Overview Table 65. Lupin Ltd Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Lupin Ltd Chronic Gastritis Treatment Product Portfolio Table 67. Lupin Ltd Recent Development Table 68. Microbiotix Company Information Table 69. Microbiotix Business Overview Table 70. Microbiotix Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Microbiotix Chronic Gastritis Treatment Product Portfolio Table 72. Microbiotix Recent Development Table 73. Perrigo Pharmaceutical Company Information Table 74. Perrigo Pharmaceutical Business Overview Table 75. Perrigo Pharmaceutical Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Perrigo Pharmaceutical Chronic Gastritis Treatment Product Portfolio Table 77. Perrigo Pharmaceutical Recent Development Table 78. RESONANCE LABORATORIES Company Information Table 79. RESONANCE LABORATORIES Business Overview Table 80. RESONANCE LABORATORIES Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. RESONANCE LABORATORIES Chronic Gastritis Treatment Product Portfolio Table 82. RESONANCE LABORATORIES Recent Development Table 83. ROLABO OUTSOURCING Company Information Table 84. ROLABO OUTSOURCING Business Overview Table 85. ROLABO OUTSOURCING Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. ROLABO OUTSOURCING Chronic Gastritis Treatment Product Portfolio Table 87. ROLABO OUTSOURCING Recent Development Table 88. SAURAV CHEMICALS Company Information Table 89. SAURAV CHEMICALS Business Overview Table 90. SAURAV CHEMICALS Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. SAURAV CHEMICALS Chronic Gastritis Treatment Product Portfolio Table 92. SAURAV CHEMICALS Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AstraZeneca Chronic Gastritis Treatment Product Portfolio Table 97. AstraZeneca Recent Development Table 98. Hangzhou Vega Company Information Table 99. Hangzhou Vega Business Overview Table 100. Hangzhou Vega Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Hangzhou Vega Chronic Gastritis Treatment Product Portfolio Table 102. Hangzhou Vega Recent Development Table 103. Wuhan Senwayer Century Company Information Table 104. Wuhan Senwayer Century Business Overview Table 105. Wuhan Senwayer Century Chronic Gastritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Wuhan Senwayer Century Chronic Gastritis Treatment Product Portfolio Table 107. Wuhan Senwayer Century Recent Development Table 108. North America Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Chronic Gastritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Chronic Gastritis Treatment Market Share by Country (2021-2026) Table 111. North America Chronic Gastritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Chronic Gastritis Treatment Market Share Forecast by Country (2027-2032) Table 113. Europe Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Chronic Gastritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Chronic Gastritis Treatment Market Share by Country (2021-2026) Table 116. Europe Chronic Gastritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Chronic Gastritis Treatment Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Chronic Gastritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Chronic Gastritis Treatment Market Share by Country (2021-2026) Table 121. Asia-Pacific Chronic Gastritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Chronic Gastritis Treatment Market Share Forecast by Country (2027-2032) Table 123. Latin America Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Chronic Gastritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Chronic Gastritis Treatment Market Share by Country (2021-2026) Table 126. Latin America Chronic Gastritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Chronic Gastritis Treatment Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa Chronic Gastritis Treatment Market Share by Country (2021-2026) Table 131. Middle East & Africa Chronic Gastritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa Chronic Gastritis Treatment Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Chronic Gastritis Treatment Product Image Figure 3. Global Chronic Gastritis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Chronic Gastritis Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Chronic Gastritis Treatment Market Share by Region (2021-2032) Figure 7. North America Chronic Gastritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Chronic Gastritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Chronic Gastritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Chronic Gastritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Chronic Gastritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. H2 Antagonists Image Figure 13. Global H2 Antagonists Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Antacids Image Figure 15. Global Antacids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Proton Pump Inhibitors Image Figure 17. Global Proton Pump Inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Chronic Gastritis Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Chronic Gastritis Treatment Market Share by Type 2025 VS 2032 Figure 22. North America Chronic Gastritis Treatment Market Size Share by Type (2021-2032) Figure 23. Europe Chronic Gastritis Treatment Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Chronic Gastritis Treatment Market Size Share by Type (2021-2032) Figure 25. Latin America Chronic Gastritis Treatment Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Chronic Gastritis Treatment Market Size Share by Type (2021-2032) Figure 27. Drug Stimulate Image Figure 28. Global Drug Stimulate Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Stress Image Figure 30. Global Stress Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Irritant Image Figure 32. Global Irritant Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Virus Infection Image Figure 34. Global Virus Infection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Chronic Gastritis Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Chronic Gastritis Treatment Market Share by Application 2025 VS 2032 Figure 39. North America Chronic Gastritis Treatment Market Size Share by Application (2021-2032) Figure 40. Europe Chronic Gastritis Treatment Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Chronic Gastritis Treatment Market Size Share by Application (2021-2032) Figure 42. Latin America Chronic Gastritis Treatment Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Chronic Gastritis Treatment Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Chronic Gastritis Treatment Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Chronic Gastritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Chronic Gastritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Chronic Gastritis Treatment Market Share by Country (2021-2032) Figure 49. Europe Chronic Gastritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Chronic Gastritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Chronic Gastritis Treatment Market Share by Country (2021-2032) Figure 52. Asia-Pacific Chronic Gastritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Chronic Gastritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Chronic Gastritis Treatment Market Share by Country (2021-2032) Figure 55. Latin America Chronic Gastritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Chronic Gastritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Chronic Gastritis Treatment Market Share by Country (2021-2032) Figure 58. Middle East & Africa Chronic Gastritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Chronic Gastritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Chronic Gastritis Treatment Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • H2 Antagonists
  • Antacids
  • Proton Pump Inhibitors
  • Others
Applications
  • Drug Stimulate
  • Stress
  • Irritant
  • Virus Infection
  • Others
Companies covered
  • Alchem International
  • Cipla
  • Katsura Chemical
  • Lupin Ltd
  • Microbiotix
  • Perrigo Pharmaceutical
  • RESONANCE LABORATORIES
  • ROLABO OUTSOURCING
  • SAURAV CHEMICALS
  • AstraZeneca
  • Hangzhou Vega
  • Wuhan Senwayer Century

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Chronic Gastritis Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Chronic Gastritis Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Chronic Gastritis Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Chronic Gastritis Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Chronic Gastritis Treatment Market Size (2021-2032)
  8. 1.5.1 North America Chronic Gastritis Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Chronic Gastritis Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Chronic Gastritis Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Chronic Gastritis Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Chronic Gastritis Treatment Market Size Growth Rate (2021-2032)
2 Chronic Gastritis Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 H2 Antagonists
  3. 2.1.2 Antacids
  4. 2.1.3 Proton Pump Inhibitors
  5. 2.1.4 Others
  6. 2.2 Global Chronic Gastritis Treatment Market Size by Type
  7. 2.2.1 Global Chronic Gastritis Treatment Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Chronic Gastritis Treatment Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Chronic Gastritis Treatment Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Chronic Gastritis Treatment Market Size by Regions
  11. 2.3.1 North America Chronic Gastritis Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Chronic Gastritis Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Chronic Gastritis Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Chronic Gastritis Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Chronic Gastritis Treatment Market Size Breakdown by Type (2021-2026)
3 Chronic Gastritis Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Drug Stimulate
  3. 3.1.2 Stress
  4. 3.1.3 Irritant
  5. 3.1.4 Virus Infection
  6. 3.1.5 Others
  7. 3.2 Global Chronic Gastritis Treatment Market Size by Application
  8. 3.2.1 Global Chronic Gastritis Treatment Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Chronic Gastritis Treatment Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Chronic Gastritis Treatment Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Chronic Gastritis Treatment Market Size by Regions
  12. 3.3.1 North America Chronic Gastritis Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Chronic Gastritis Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Chronic Gastritis Treatment Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Chronic Gastritis Treatment Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Chronic Gastritis Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Chronic Gastritis Treatment Industry Trends
  2. 4.2 Chronic Gastritis Treatment Industry Drivers
  3. 4.3 Chronic Gastritis Treatment Industry Opportunities and Challenges
  4. 4.4 Chronic Gastritis Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Chronic Gastritis Treatment Revenue (2021-2026)
  2. 5.2 Global Chronic Gastritis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Chronic Gastritis Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Chronic Gastritis Treatment Company, Product Type & Application
  5. 5.5 Global Chronic Gastritis Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Chronic Gastritis Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Chronic Gastritis Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Chronic Gastritis Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Alchem International
  2. 6.1.1 Alchem International Company Information
  3. 6.1.2 Alchem International Business Overview
  4. 6.1.3 Alchem International Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Alchem International Chronic Gastritis Treatment Product Portfolio
  6. 6.1.5 Alchem International Recent Developments
  7. 6.2 Cipla
  8. 6.2.1 Cipla Company Information
  9. 6.2.2 Cipla Business Overview
  10. 6.2.3 Cipla Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Cipla Chronic Gastritis Treatment Product Portfolio
  12. 6.2.5 Cipla Recent Developments
  13. 6.3 Katsura Chemical
  14. 6.3.1 Katsura Chemical Company Information
  15. 6.3.2 Katsura Chemical Business Overview
  16. 6.3.3 Katsura Chemical Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Katsura Chemical Chronic Gastritis Treatment Product Portfolio
  18. 6.3.5 Katsura Chemical Recent Developments
  19. 6.4 Lupin Ltd
  20. 6.4.1 Lupin Ltd Company Information
  21. 6.4.2 Lupin Ltd Business Overview
  22. 6.4.3 Lupin Ltd Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Lupin Ltd Chronic Gastritis Treatment Product Portfolio
  24. 6.4.5 Lupin Ltd Recent Developments
  25. 6.5 Microbiotix
  26. 6.5.1 Microbiotix Company Information
  27. 6.5.2 Microbiotix Business Overview
  28. 6.5.3 Microbiotix Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Microbiotix Chronic Gastritis Treatment Product Portfolio
  30. 6.5.5 Microbiotix Recent Developments
  31. 6.6 Perrigo Pharmaceutical
  32. 6.6.1 Perrigo Pharmaceutical Company Information
  33. 6.6.2 Perrigo Pharmaceutical Business Overview
  34. 6.6.3 Perrigo Pharmaceutical Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Perrigo Pharmaceutical Chronic Gastritis Treatment Product Portfolio
  36. 6.6.5 Perrigo Pharmaceutical Recent Developments
  37. 6.7 RESONANCE LABORATORIES
  38. 6.7.1 RESONANCE LABORATORIES Company Information
  39. 6.7.2 RESONANCE LABORATORIES Business Overview
  40. 6.7.3 RESONANCE LABORATORIES Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 RESONANCE LABORATORIES Chronic Gastritis Treatment Product Portfolio
  42. 6.7.5 RESONANCE LABORATORIES Recent Developments
  43. 6.8 ROLABO OUTSOURCING
  44. 6.8.1 ROLABO OUTSOURCING Company Information
  45. 6.8.2 ROLABO OUTSOURCING Business Overview
  46. 6.8.3 ROLABO OUTSOURCING Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 ROLABO OUTSOURCING Chronic Gastritis Treatment Product Portfolio
  48. 6.8.5 ROLABO OUTSOURCING Recent Developments
  49. 6.9 SAURAV CHEMICALS
  50. 6.9.1 SAURAV CHEMICALS Company Information
  51. 6.9.2 SAURAV CHEMICALS Business Overview
  52. 6.9.3 SAURAV CHEMICALS Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 SAURAV CHEMICALS Chronic Gastritis Treatment Product Portfolio
  54. 6.9.5 SAURAV CHEMICALS Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca Chronic Gastritis Treatment Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
  61. 6.11 Hangzhou Vega
  62. 6.11.1 Hangzhou Vega Company Information
  63. 6.11.2 Hangzhou Vega Business Overview
  64. 6.11.3 Hangzhou Vega Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Hangzhou Vega Chronic Gastritis Treatment Product Portfolio
  66. 6.11.5 Hangzhou Vega Recent Developments
  67. 6.12 Wuhan Senwayer Century
  68. 6.12.1 Wuhan Senwayer Century Company Information
  69. 6.12.2 Wuhan Senwayer Century Business Overview
  70. 6.12.3 Wuhan Senwayer Century Chronic Gastritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Wuhan Senwayer Century Chronic Gastritis Treatment Product Portfolio
  72. 6.12.5 Wuhan Senwayer Century Recent Developments
7 North America
  1. 7.1 North America Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Chronic Gastritis Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Chronic Gastritis Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Chronic Gastritis Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Chronic Gastritis Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Chronic Gastritis Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Chronic Gastritis Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Chronic Gastritis Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Chronic Gastritis Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Chronic Gastritis Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst